Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia

Molecular and Cellular Endocrinology

Volumn 320, Issue 1-2, 2010, Pages 76-86

  Schwartz, Jason R ^a   Sarvaiya, Purvaba J ^a   Vedeckis, Wayne V ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lymphoblastic leukemia; Apoptosis; Auto regulation; Glucocorticoid receptor; Threshold

Indexed keywords

DEXAMETHASONE; DOXYCYCLINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; SHORT HAIRPIN RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL LINEAGE; CELL STRAIN HEK293; CELL VIABILITY; CONTROLLED STUDY; DRUG SENSITIVITY; EMBRYO; GENETIC REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DEXAMETHASONE; DOXYCYCLINE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SPACE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; RNA, SMALL INTERFERING; TITRIMETRY;

EID: 77949653920     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.014     Document Type: Article

References (42)

1. Abrams M.T., Robertson N.M., Yoon K., Wickstrom E. Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J. Biol. Chem. 2004, 279:55809-55817.
2. Ashraf J., Kunapuli S., Chilton D., Thompson E.B. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells. J. Steroid Biochem. Mol. Biol. 1991, 38:561-568.
3. Ashraf J., Thompson E.B. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Mol. Endocrinol. 1993, 7:631-642.
4. Bachmann P.S., Gorman R., Papa R.A., Bardell J.E., Ford J., Kees U.R., Marshall G.M., Lock.R.B. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Res. 2007, 67:4482-4490.
5. Barrett T.J., Vig E., Vedeckis W.V. Coordinate regulation of glucocorticoid receptor and c-jun gene expression is cell-type specific and exhibits differential hormonal sensitivity for down- and up-regulation. Biochemistry 1996, 35:9746-9753.
6. Delfino D.V., Agostini M., Spinicelli S., Vito P., Riccardi C. Decrease of Bcl-X and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 2004, 104:4134-4141.
7. Dordelmann M., Reiter A., Borkhardt A., Ludwig W.D., Gotz N., Viehmann S., Gadner H., Riehm H., Schrappe M. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999, 94:1209-1217.
8. Geng C.-d., Vedeckis W.V. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. J. Biol. Chem. 2005, 280:43264-43271.
9. Geng J.R., Schwartz W.V., Vedeckis A conserved molecular mechanism is responsible for the auto-up-regulation of glucocorticoid receptor gene promoters. Mol. Endocrinol. 2008, 22:2624-2642.
10. Gomi M., Moriwaki K., Katagiri S., Kurata Y., Thompson E.B. Glucocorticoid effects on myeloma cells in culture: correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA. Cancer Res. 1990, 50:1873-1878.
11. Gross K.L., Cidlowski J.A. Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol. Metab. 2008, 19:331-339.
12. Gruber G., Carlet M., Turtscher E., Meister B., Irving J.A., Ploner C., Kofler R. Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis. Leukemia 2009, 23:820-823.
13. Grugan K.D., Ma C., Singhal S., Krett N.L., Rosen S.T. Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myeloma. J. Steroid Biochem. Mol. Biol. 2008, 110:244-254.
14. Ji Z., Mei F.C., Miller A.L., Thompson E.B., Cheng X. Protein kinase A (PKA) isoform RIIβ mediates the synergistic killing effect of cAMP and glucocorticoid in acute lymphoblastic leukemia cells. J. Biol. Chem. 2008, 283:21920-21925.
15. Kato G.J., Quddus F.F., Shuster J.J., Boyett J., Pullen J.D., Borowitz M.J., Whitehead V.M., Crist W.M., Leventhal B.G. High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 1993, 82:2304-2309.
16. Keith B.D. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy. BMC Cancer 2008, 8:84.
17. Kfir S., Sionov R.V., Zafrir E., Zilberman Y., Yefenof E. Staurosporine sensitizes T lymphoma cells to glucocorticoid-induced apoptosis: role of Nur77 and Bcl-2. Cell Cycle 2007, 6:3086-3096.
18. Kofler R., Schmidt S., Kofler A., Ausserlechner M.J. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J. Endocrinol. 2003, 178:19-27.
19. Langebrake C., Reinhardt D., Ritter J. Minimising the long-term adverse effects of childhood leukaemia therapy. Drug Saf. 2002, 25:1057-1077.
20. Ma J., Xie Y., Shi Y., Qin W., Zhao B., Jin.Y. Glucocorticoid-induced apoptosis requires FOXO3A activity. Biochem. Biophys. Res. Commun. 2008, 377:894-898.
21. Medh R.D., Wang A., Zhou F., Thompson E.B. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells. Oncogene 2001, 20:4629-4639.
22. Miller A.L., Garza A.S., Johnson B.H., Thompson E.B. Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Cancer Cell Int. 2007, 7:3.
23. Myoumoto A., Nakatani K., Koshimizu T.-a., Matsubara H., Adachi S., Tsujimoto G. Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy. J. Hum. Genet. 2007, 52:328-333.
24. Palmer L.A., Hukku B., Harmon J.M. Human glucocorticoid receptor gene deletion following exposure to cancer chemotherapeutic drugs and chemical mutagens. Cancer Res. 1992, 52:6612-6618.
25. Pedersen K.B., Vedeckis W.V. Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines. Biochemistry 2003, 42:10978-10990.
26. Powers J.H., Hillmann A.G., Tang D.C., Harmon J.M. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells. Cancer Res. 1993, 53:4059-4065.
27. Pui C.H., Costlow M.E. Sequential studies of lymphoblast glucocorticoid receptor levels at diagnosis and relapse in childhood leukemia: an update. Leuk. Res. 1986, 10:227-229.
28. Ramdas J., Liu W., Harmon J.M. Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. Cancer Res. 1999, 59:1378-1385.
29. Riml S., Schmidt S., Ausserlechner M.J., Geley S., Kofler R. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Cell Death Differ. 2004, 1(11 Suppl.):S65-72.
30. Schaaf M.J., Cidlowski J.A. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol. 2002, 83:37-48.
31. Schwartz C.L., Thompson E.B., Gelber R.D., Young M.L., Chilton D., Cohen H.J., Sallan S.E. Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. J. Clin. Oncol. 2001, 19:1040-1046.
32. Sionov R.V., Spokoini R., Kfir-Erenfeld S., Cohen O., Yefenof E. Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis. Adv. Cancer Res. 2008, 101:127-248.
33. Tissing W.J., Meijerink J.P., den Boer M.L., Pieters R. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003, 17:17-25.
34. Tissing W.J., Lauten M., Meijerink J.P., den Boer M.L., Koper J.W., Sonneveld P., Pieters R. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia. Haematologica 2005, 90:1279-1281.
35. Tissing W.J., Meijerink J.P., Brinkhof B., Broekhuis M.J., Menezes R.X., den Boer M.L., Pieters R. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL. Blood 2006, 108:1045-1049.
36. Wang Z., Malone M.H., He H., McColl K.S., Distelhorst C.W. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple model of glucocorticoid-induced apoptosis. J. Biol. Chem. 2003, 278:23861-23867.
37. Webster J.C., Cidlowski J.A. Mechanisms of glucocorticoid-receptor-mediated repression of gene expression. Trends Endocrinol. Metab. 1999, 10:396-402.
38. Wiegers G.J., Knoflach M., Bock G., Niederegger H., Dietrich H., Falus A., Boyd R., Wick.G. CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur. J. Immunol. 2001, 31:2293-2301.
39. Wright A.P., Zilliacus J., McEwan I.J., Dahlman-Wright K., Almlof T., Carlstedt-Duke J., Gustafsson J.A. Structure and function of the glucocorticoid receptor. J. Steroid Biochem. Mol. Biol. 1993, 47:11-19.
40. Yamada M., Hirasawa A., Shiojima S., Tsujimoto G. Granzyme a mediates glucocorticoid-induced apoptosis in leukemia cells. FASEB J. 2003, 17:1712-1714.
41. Zhang L., Insel P.A. The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J. Biol. Chem. 2004, 279:20858-20865.
42. Zhou F., Thompson E.B. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. Mol. Endocrinol. 1996, 10:306-316.